We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
The Pediatric Forum |

Reassessing Reye Syndrome

Emilie L. Chow, MD; James D. Cherry, MD; Rick Harrison, MD; Sue V. McDiarmid, MD; Sunita Bhuta, MD
Arch Pediatr Adolesc Med. 2003;157(12):1241-1242. doi:10.1001/archpedi.157.12.1241.
Text Size: A A A
Published online


In 1963, Reye and associates1 described a syndrome in 21 children, characterized by acute encephalopathy, hepatic steatosis, and elevated levels of serum transaminases. Subsequent studies in the 1960s and 1970s revealed that it was a virus-related illness mainly associated with antecedent influenza B and varicella virus infections. In 1977, 454 cases of Reye syndrome were reported in the United States, and of 373 cases with follow-up, 42% died and 11% had residual neurologic damage.2 In the late 1970s and early 1980s, a number of case-control studies described an association between aspirin ingestion and the development of Reye syndrome.3 The Committee of Infectious Disease of the American Academy of Pediatrics and the Centers for Disease Control and Prevention recommended that aspirin-containing products not be given to children. In 1986, a warning label was required for all aspirin-containing products sold in the United States. In the last 2 decades, reported Reye syndrome cases have fallen from 555 in 1980 to fewer than 2 per year from 1994 through 1997.3 We report a case of a child with aspirin-related Reye syndrome to emphasize the continued risk of this potentially fatal disease.

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

2 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Related Collections
PubMed Articles